Page Content
to Navigation
- BUSSE R, SCHREYÖGG J, SMITH P (2008): Variability in healthcare treatment costs amongst nine EU countries – results from HealthBASKET project (Editorial). Health Economics 17(S1): 1-8
- Blankart C, von Reitzenstein R (2008): Perspectives of dose-dispensed medicine (DDM) in Germany. PharmacoEconomics – German Research Articles; 6(2): 79-88
- Blankart R, Schreyögg J, Busse R (2008): Performance of tariff schemes in valuation of technologies: the example of Magnetic Resonance Imaging. Technology and Health Care 16(3): 171-182
- Borgonovi E, Busse R, Kanavos P (2008): Financing medical devices in Europe: Current trends and perspectives for research. Eurohealth 14(3): 1-3
- Maier B, Thimme W, Schoeller R, Fried A, Behrens S, Theres H (2008):Improved therapy and outcome for patients with acute myocardial infarction - Data of the Berlin Myocardial Infarction Registry from 1999 to 2004. International Journal of Cardiology 130(2
- Krajewski Siuda K, Romaniuk P, Gericke CA. Political analysis of the conception of the Polish National Health Fund. J Public Health (Berl) 2008, 16: 153-159.
- Koppel A, Kahur K, Habicht T, Saar P, Habicht J and van Ginneken E. Estonia: Health system review. Health Systems in Transition. 2008; 10(1): 1-230
- Schlette S, Blum K, Busse R (eds.) (2008): Health Policy Developments 9. Focus on Mental Health, New Role for Hospitals, Search for the right Funding Mix. Gütersloh: Bertelsmann Foundation Publishers
- Schlette S, Blum K, Busse R (eds.) (2008): Health Policy Developments 9. Focus on Mental Health, New Role for Hospitals, Search for the right Funding Mix. Gütersloh: Bertelsmann Foundation Publishers
- Schreyögg J (2008): A micro-costing approach to estimating hospital costs for appendectomy in a Cross-European. Health Economics 17(S1): S59-S69
- Schreyögg J, von Reitzenstein C (2008): Strategic groups and performance differences among academic medical centers.Health Care Management Review: 33(3):225-233
- Schreyögg J, Tiemann O, Stargardt T, Busse R (2008): Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories. Health Economics 17(S1): S95-S103
- Sorenson C, Drummond M, Kristensen F, Busse R (2008): Policy Brief „How can the impact of health technology assessments be enhanced?“ Copenhagen: WHO Regional Office for Europe
- Stargardt T (2008): Health service costs in Europe: cost and reimbursement of primary hip replacement in nine countries. Health Economics 17(S1): S9-S20
- Pharmaceutical Pricing and Reimbursement Information project(2008): GERMANY. European Commission, Health and Consumer Protection Directorate-General and Austrian Ministry of Health, Family and Youth
- Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA (2008): Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care. J Ment Health Policy Econ; 11: 89-97.
- Tiemann O (2008): Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe. Health Economics 17(S1): S33-S45
- Tragakes E, Brigis G, Karaskevica J, Rurane A, Stuburs A, Zusmane E, Avdeeva O and Schäfer M. Latvia: Health system review. Health Systems in Transition. 2008; 10(2): 1–253
- van Ginneken E, Busse R, Gericke CA (2008):Universal private health insurance in the Netherlands: The first year. Journal of Management & Marketing in Healthcare 1(2): 139-153
- Velasco-Garrido M, Børlum Kristensen F, Palmhøj Nielsen C, Busse R (2008): Health technology assessment and health policy-making in Europe – Current status, challenges and potential. Copenhagen: WHO Regional Office for Europe